All Stories

  1. STING-mediated antiviral response: insights into MVA replication control in avian cells
  2. Chronic Exposure to Chlorpyrifos Damages Thyroid Activity and Imbalances Hepatic Thyroid Hormones Signaling and Glucose Metabolism: Dependency of T3-FOXO1 Axis by Hyperglycemia
  3. The Lack of STING Impairs the MHC-I Dependent Antigen Presentation and JAK/STAT Signaling in Murine Macrophages
  4. Thyroid Cancer and Fibroblasts
  5. miRNA-23a modulates sodium-hydrogen exchanger 1 expression: studies in medullary thick ascending limb of salt-induced hypertensive rats
  6. ZFP36L2 Role in Thyroid Functionality
  7. Application of Bioactive Compounds and Drugs to Target Epigenetic Enzymes and Non-coding RNAs, Exploiting New Delivery Systems for Cancer Therapy
  8. Generation of a Novel Mesothelin-Targeted Oncolytic Herpes Virus and Implemented Strategies for Manufacturing
  9. Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Herpes Simplex Oncolytic Virus
  10. Peripheral T3 signaling is the target of pesticides in zebrafish larvae and adult liver
  11. Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs
  12. Thyroid Hormones and Functional Ovarian Reserve: Systemic vs. Peripheral Dysfunctions
  13. Editorial
  14. Insights into Thymus Development and Viral Thymic Infections
  15. Effects of Long-Term Citrate Treatment in the PC3 Prostate Cancer Cell Line
  16. Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α
  17. A Toxicogenomic Approach Reveals a Novel Gene Regulatory Network Active in In Vitro and In Vivo Models of Thyroid Carcinogenesis
  18. Transcriptional landscape of mouse-aged ovaries reveals a unique set of non-coding RNAs associated with physiological and environmental ovarian dysfunctions
  19. Genetic background and window of exposure contribute to thyroid dysfunction promoted by low-dose exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice
  20. The expression of inhibitor of bruton’s tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis
  21. Carcinogenic risk and Bisphenol A exposure: A focus on molecular aspects in endoderm derived glands
  22. Pesticide toxicogenomics across scales: in vitro transcriptome predicts mechanisms and outcomes of exposure in vivo
  23. Roles of microRNAs in HIV-1 Replication and Latency
  24. The Roles of miR-25 and its Targeted Genes in Development of Human Cancer
  25. Molecular targets of developmental exposure to bisphenol A in diabesity: a focus on endoderm-derived organs
  26. “Stockpile” of Slight Transcriptomic Changes Determines the Indirect Genotoxicity of Low-Dose BPA in Thyroid Cells
  27. Evaluation of low doses BPA-induced perturbation of glycemia by toxicogenomics points to a primary role of pancreatic islets and to the mechanism of toxicity
  28. Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice
  29. RNA Viruses: RNA Roles in Pathogenesis, Coreplication and Viral Load
  30. Pharmacological folding chaperones act as allosteric ligands of Frizzled4
  31. Cross-species toxicogenomic analyses and phenotypic anchoring in response to groundwater low-level pollution
  32. Cancer-Associated CD43 Glycoforms as Target of Immunotherapy
  33. A disorder-to-order structural transition in the COOH-tail of Fz4 determines misfolding of the L501fsX533-Fz4 mutant
  34. Bisphenol A interferes with thyroid specific gene expression
  35. miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors
  36. FKBP51 and the NF-κB regulatory pathway in cancer
  37. Non-coding RNAs change their expression profile after Retinoid induced differentiation of the promyelocytic cell line NB4
  38. Endoplasmic reticulum stress reduces the export from the ER and alters the architecture of post-ER compartments
  39. Computational analysis and in vivo validation of a microRNA encoded by the IBTK gene, a regulator of B-lymphocytes differentiation and survival
  40. Molecular mechanisms of dendritic mRNA localization and its implication for learning and memory
  41. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF- B pathway
  42. Non-protein coding RNA biomarkers and differential expression in cancers: a review
  43. TEF-1 and C/EBPβ are major p38α MAPK-regulated transcription factors in proliferating cardiomyocytes
  44. A GFP-based System to Uncouple mRNA Transport from Translation in a Single Living Neuron
  45. Isolation and characterization of Staufen-containing ribonucleoprotein particles from rat brain
  46. Relationship between Vaccinia Virus Intracellular Cores, Early mRNAs, and DNA Replication Sites
  47. Microtubule-dependent Organization of Vaccinia Virus Core-derivd Early mRNAs into Distinct Cytoplasmic Structures
  48. Potent and Stable Attenuation of Live-HIV-1 by Gain of a Proteolysis-resistant Inhibitor of NF-κB (IκB-αS32/36A) and the Implications for Vaccine Development
  49. HIV-1 Tat Induces the Expression of the Interleukin-6 (IL6) Gene by Binding to the IL6 Leader RNA and by Interacting with CAAT Enhancer-binding Protein β (NF-IL6) Transcription Factors
  50. Regulation of HIV-1 Long Terminal Repeats by Interaction of C/EBP(NF-IL6) and NF-κB/Rel Transcription Factors
  51. An NF-κB Site in the 5′-Untranslated Leader Region of the Human Immunodeficiency Virus Type 1 Enhances the Viral Expression in Response to NF-κB-activating Stimuli
  52. Regulation of NF-kappaB through the Nuclear Processing of p105 (NF-kappaB1) in Epstein-Barr Virus-immortalized B Cell Lines
  53. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.
  54. Molecular Mechanisms of the Development of EBV-Related B Lymphomas: Functional Cooperation of EBV with IL-6 and HIV-1
  55. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1
  56. Spontaneous and mutagen-mediated amplification of a neo gene integrated at different genomic sites in Rat 2 fibroblasts
  57. Enhanced transcription of interleukin 1 (IL-1) and interleukin 6 (IL-6) in mutagen-treated human monocytes
  58. Ultraviolet Mutagenesis
  59. Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity.
  60. Effect of DNOC, Ferbam and Imidan exposure on mouse sperm morphology